Leiden Jeffrey M's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 14, 2024
- Accession no.
- 0000875320-24-000059
- Filed
- Feb 14, 2024
- Trade date
- Feb 12-13, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $1.42M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leiden Jeffrey MCIK 0001242825 | Director, Officer (Executive Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Common Stock | SSaleDisposed | −2,009 | $419.22F2,F3 | −$842,212.98 | 28,291 | Direct | |
| Feb 12, 2024 | Common Stock | SSaleDisposed | −647 | $420.39F2,F4 | −$271,992.33 | 27,644 | Direct | |
| Feb 13, 2024 | Common Stock | SSaleDisposed | −737 | $419.13F2,F5 | −$308,898.81 | 26,907 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $419.22 (range $419.00 to $419.71).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $420.39 (range $420.21 to $420.94).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $419.13 (range $419.00 to $419.37).
Referenced by the price of 1 transaction in Table I.